RWA Wealth Partners’s Boston Scientific BSX Stock Holding History

RWA Wealth Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$377K	Sell	6,009 -40	-0.7%	-$3.2K	﹤0.01%	497
2025 Q4	$577K	Buy	6,049 +79	+1%	+$7.75K	0.01%	418
2025 Q3	$583K	Buy	5,970 +250	+4%	+$25.9K	0.01%	417
2025 Q2	$614K	Hold	5,720	–	–	0.01%	398
2025 Q1	$577K	Sell	5,720 -265	-4%	-$26.7K	0.01%	392
2024 Q4	$535K	Buy	5,985 +33	+0.6%	+$2.9K	0.01%	406
2024 Q3	$499K	Buy	5,952 +3,039	+104%	+$240K	0.01%	402
2024 Q2	$224K	Buy	+2,913	New	+$213K	﹤0.01%	513
2018 Q3	–	Sell	-57	Closed	-$2K	–	292
2018 Q2	$2K	Hold	57	–	–	﹤0.01%	744
2018 Q1	$2K	Buy	+57	New	+$1.55K	﹤0.01%	544

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RWA Wealth Partners's BSX Position: Q1 2026 in Review

RWA Wealth Partners reduced its Boston Scientific (BSX) stake by 0.66% in Q1 2026, selling an estimated $3.2K and leaving 6,009 shares worth $377K. The position accounts for ﹤0.01% of the portfolio, ranked #497.

RWA Wealth Partners first reported a position in BSX in Q1 2018 and has held it in 10 quarters since. The position peaked at $614K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

RWA Wealth Partners held 6,009 shares of Boston Scientific worth $377K as of Q1 2026.
RWA Wealth Partners sold 40 Boston Scientific shares in Q1 2026, an estimated $3.2K.
Boston Scientific made up ﹤0.01% of RWA Wealth Partners's portfolio in Q1 2026, its #497 holding.
RWA Wealth Partners first reported a position in Boston Scientific in Q1 2018 and has held it in 10 quarters since.
RWA Wealth Partners's Boston Scientific position peaked at $614K in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on RWA Wealth Partners's 13F filing for Q1 2026, filed 13 May 2026.